(Q80530384)
English
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and compa
scientific article published on 01 July 2007
Statements
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients (English)
Marino Clavio
Luana Vignolo
Alessandra Albarello
Riccardo Varaldo
Ivana Pierri
Gioacchino Catania
Manuela Balocco
Gianluca Michelis
Maurizio Miglino
Annunziata Manna
Enrico Balleari
A Michele Carella
Mario Sessarego
Maria Teresa Van Lint
Andrea Bacigalupo